Tandem Diabetes Care (TNDM) Retained Earnings (2016 - 2026)
Tandem Diabetes Care filings provide 13 years of Retained Earnings readings, the most recent being $5.6 million for Q4 2025.
- On a quarterly basis, Retained Earnings rose 387.26% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 387.26% increase, with the full-year FY2025 number at $5.6 million, up 387.26% from a year prior.
- Retained Earnings hit $5.6 million in Q4 2025 for Tandem Diabetes Care, up from $5.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $5.6 million in Q4 2025 to a low of -$1.0 billion in Q3 2024.
- Median Retained Earnings over the past 5 years was -$1.9 million (2022), compared with a mean of -$327.8 million.
- Biggest five-year swings in Retained Earnings: plummeted 5095357.14% in 2022 and later soared 398.88% in 2025.
- Tandem Diabetes Care's Retained Earnings stood at -$616000.0 in 2021, then crashed by 194.97% to -$1.8 million in 2022, then plummeted by 52283.05% to -$951.8 million in 2023, then surged by 99.8% to -$1.9 million in 2024, then soared by 387.26% to $5.6 million in 2025.
- The last three reported values for Retained Earnings were $5.6 million (Q4 2025), $5.2 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.